Function and genetics of dystrophin and dystrophin-related proteins in muscle.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Physiological Reviews

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/PHYSREV.00028.2001PMID 11917091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse

  2004cited by this paper
• Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse

  2004cited by this paper
• Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle

  2004cited by this paper
• Eine neue x-chromosomale Muskeldystrophie

  2004influential reference
• The Dystroglycan Complex Is Necessary for Stabilization of Acetylcholine Receptor Clusters at Neuromuscular Junctions and Formation of the Synaptic Basement Membrane

  2001cited by this paper
• Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.

  2001cited by this paper
• Calcium currents and transients in co‐cultured contracting normal and Duchenne muscular dystrophy human myotubes

  2001cited by this paper
• Apoptosis in skeletal muscle.

  2001cited by this paper
• An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy

  2001cited by this paper
• Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.

  2001cited by this paper
• Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C.

  2001cited by this paper
• Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old

  2001cited by this paper
• Desmuslin, an intermediate filament protein that interacts with α-dystrobrevin and desmin

  2001cited by this paper
• Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.

  2001cited by this paper
• Syncoilin, a Novel Member of the Intermediate Filament Superfamily That Interacts with α-Dystrobrevin in Skeletal Muscle*

  2001cited by this paper
• Alteration in Calcium Handling at the Subcellular Level inmdx Myotubes*

  2001cited by this paper
• Role of beta-dystrobrevin in nonmuscle dystrophin-associated protein complex-like complexes in kidney and liver.

  2001cited by this paper
• Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging.

  2001cited by this paper
• Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain*

  2001influential reference
• Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.

  2001cited by this paper
• Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse.

  2001cited by this paper
• The complexities of dystroglycan.

  2001cited by this paper
• Coiled coils: a highly versatile protein folding motif.

  2001cited by this paper
• Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly.

  2001cited by this paper
• NO vascular control in Duchenne muscular dystrophy

  2001cited by this paper
• Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin.

  2001cited by this paper
• A novel mechanism for modulating synaptic gene expression: differential localization of alpha-dystrobrevin transcripts in skeletal muscle.

  2001cited by this paper
• Molecular, genetic and physiological characterisation of dystrobrevin-like (dyb-1) mutants of Caenorhabditis elegans.

  2001cited by this paper
• Enhanced Expression of the α7β1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice

  2001cited by this paper
• Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events.

  2001cited by this paper
• Distinct regions in the 3′ untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells

  2001cited by this paper
• Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.

  2001cited by this paper
• Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients.

  2001cited by this paper
• Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy

  2001cited by this paper
• Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome

  2001cited by this paper
• Relevance of IGF-I, IGFBP-3, and IGFBP-2 Measurements during GH Treatment of GH-Deficient and Non-GH-Deficient Children and Adolescents

  2001cited by this paper
• Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.

  2001cited by this paper
• Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration

  2000cited by this paper
• Assembly of multiple dystrobrevin-containing complexes in the kidney.

  2000cited by this paper
• Expression of γ-Sarcoglycan in Smooth Muscle and Its Interaction with the Smooth Muscle Sarcoglycan-Sarcospan Complex*

  2000cited by this paper
• The Dystrophin Complex Forms a Mechanically Strong Link between the Sarcolemma and Costameric Actin

  2000cited by this paper
• Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.

  2000cited by this paper
• Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmdmdx and Dmdmdx3cv dystrophin-deficient mice

  2000cited by this paper
• Calcium Influx through Calcium Leak Channels Is Responsible for the Elevated Levels of Calcium-dependent Proteolysis in Dystrophic Myotubes*

  2000influential reference
• Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF.

  2000cited by this paper
• Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by epsilon-AChR subunit truncating mutations.

  2000cited by this paper
• Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.

  2000cited by this paper
• Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies.

  2000cited by this paper
• Spectrin tethers and mesh in the biosynthetic pathway.

  2000cited by this paper
• A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system.

  2000cited by this paper
• The artificial zinc finger coding gene ‘Jazz’ binds the utrophin promoter and activates transcription

  2000cited by this paper
• Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells.

  2000cited by this paper
• The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle

  2000cited by this paper
• Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene

  2000cited by this paper
• Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice.

  2000cited by this paper
• Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice.

  2000cited by this paper
• Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice.

  2000cited by this paper
• Skeletal muscle regeneration and the mitotic clock.

  2000cited by this paper
• Structure of the utrophin actin-binding domain bound to F-actin reveals binding by an induced fit mechanism.

  2000cited by this paper
• Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans.

  2000cited by this paper
• Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.

  2000cited by this paper
• Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.

  2000cited by this paper
• Increased Activity of Calcium Leak Channels Caused by Proteolysis Near Sarcolemmal Ruptures

  2000cited by this paper
• Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology

  2000cited by this paper
• Increased expression of IGF‐binding protein‐5 in Duchenne Muscular Dystrophy (DMD) fibroblasts correlates with the fibroblast‐induced downregulation of DMD myoblast growth: An in vitro analysis

  2000cited by this paper
• Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice.

  2000cited by this paper
• The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

  2000cited by this paper
• The neurobiology of duchenne muscular dystrophy: learning lessons from muscle?

  2000cited by this paper
• Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex.

  2000cited by this paper
• Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure.

  2000cited by this paper
• Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex.

  2000cited by this paper
• Caenorhabditis elegans β-G Spectrin Is Dispensable for Establishment of Epithelial Polarity, but Essential for Muscular and Neuronal Function

  2000cited by this paper
• The Ets Transcription Factor GABP Is Required for Postsynaptic Differentiation In Vivo

  2000cited by this paper
• Contrast agent‐enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy

  2000cited by this paper
• Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children.

  2000cited by this paper
• Biochemical characterisation of the actin-binding properties of utrophin.

  2000cited by this paper
• Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

  2000cited by this paper
• Syntrophin isoforms at the neuromuscular junction: developmental time course and differential localization.

  2000cited by this paper
• Mutations in β-Spectrin Disrupt Axon Outgrowth and Sarcomere Structure

  2000cited by this paper
• Absence of α-Syntrophin Leads to Structurally Aberrant Neuromuscular Synapses Deficient in Utrophin

  2000influential reference
• Contribution of the different modules in the utrophin carboxy‐terminal region to the formation and regulation of the DAP complex

  2000cited by this paper
• Filamin 2 (Fln2)

  2000cited by this paper
• Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.

  2000cited by this paper
• Characterization, chromosomal localization, and the complete 30-kb DNA sequence of the human Jagged2 (JAG2) gene.

  2000cited by this paper
• Assembly of the Dystrophin-Associated Protein Complex Does Not Require the Dystrophin Cooh-Terminal Domain

  2000cited by this paper
• Pre-clinical screening of drugs using the mdx mouse.

  2000cited by this paper
• Animal models for muscular dystrophy: valuable tools for the development of therapies.

  2000cited by this paper
• Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan

  2000cited by this paper
• Integrin cytoplasmic domain-binding proteins.

  2000cited by this paper
• T-Cell-Dependent Fibrosis in the mdx Dystrophic Mouse

  2000cited by this paper
• Immature end-plates and utrophin deficiency in congenital myasthenic syndrome caused by ε-AChR subunit truncating mutations

  2000cited by this paper
• Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy.

  2000cited by this paper
• Drosophila β Spectrin Functions Independently of α Spectrin to Polarize the Na,k Atpase in Epithelial Cells

  2000cited by this paper
• In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide

  2000cited by this paper
• Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.

  2000cited by this paper
• Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels.

  2000cited by this paper
• Proteasome expression in the skeletal muscles of patients with muscular dystrophy

  2000cited by this paper
• Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease.

  2000cited by this paper
• Expression Profiling in the Muscular Dystrophies

  2000cited by this paper
• Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein

  2000cited by this paper

• ECG and imaging manifestations of cardiomyopathy in adults with Duchenne muscular dystrophy

  2026cites this paper
• A combinatorial oligonucleotide therapy to improve dystrophin restoration and dystrophin-deficient muscle health

  2025cites this paper
• Assessment of skeletal muscle deformability during clinical paralysis in EAE, a mouse model of multiple sclerosis.

  2025cites this paper
• Trends in Corticosteroid Use Among Males With Duchenne Muscular Dystrophy (DMD) During 2000-2015: Data From the MD STARnet.

  2025cites this paper
• Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies

  2025cites this paper
• Vamorolone – a corticosteroid approved by global regulators for the treatment of Duchenne muscular dystrophy. Literature review

  2025cites this paper
• Dystrophinopathy in the paravertebral muscle of adolescent idiopathic scoliosis: a prospective case-control study in China

  2025cites this paper
• Current Concept Review: Orthopaedic Management in Duchenne Muscular Dystrophy

  2025cites this paper
• Fibroblast growth factor–inducible 14 regulates satellite cell self-renewal and expansion during skeletal muscle repair

  2025cites this paper
• Fibroblast growth factor-inducible 14 regulates satellite cell self-renewal and expansion during skeletal muscle repair

  2025cites this paper
• EMILIN1 emerges as a TGFβ/SETDB1-regulated secreted biomarker in Duchenne Muscular Dystrophy

  2025cites this paper
• Transcriptional adaptation upregulates utrophin in Duchenne muscular dystrophy

  2025cites this paper
• Optimized genomic editing of a common Duchenne muscular dystrophy mutation in patient-derived muscle cells and a new humanized mouse model

  2025cites this paper
• Brain Matters in Duchenne Muscular Dystrophy: DMD Mutation Sites and Their Association with Neurological Comorbidities Through Isoform Impairment

  2025cites this paper
• Histone deacetylase inhibition with givinostat: a multi-targeted mode of action with the potential to halt the pathological cascade of Duchenne muscular dystrophy

  2025cites this paper
• Hyperactivation of Transforming Growth Factor-β–Activated Kinase 1 Causes Skeletal Muscle Pathology Reminiscent of Inflammatory Myopathies

  2025cites this paper
• Behavioral improvement in dystrophic mdx23 mouse following repeated antisense oligonucleotides injections

  2025cites this paper
• Advancing antisense oligonucleotide delivery through click chemistry based chemical conjugation with designed short non-cationic peptides for Duchenne muscular dystrophy.

  2025cites this paper
• Astrocyte proliferation in the hippocampal dentate gyrus is suppressed across the lifespan of dystrophin‐deficient mdx mice

  2025cites this paper
• Characterization of a humanized mouse model of Duchenne muscular dystrophy to support the development of genetic medicines

  2025cites this paper
• Architecture and molecular machinery of skeletal myofibers: a systematic review of the structure–function relationships

  2025cites this paper
• Misregulation of the Ubiquitin–Proteasome System and Autophagy in Muscular Dystrophies Associated with the Dystrophin–Glycoprotein Complex

  2025influential citation
• The prospects and challenges of small molecule drugs in the treatment of Duchenne muscular dystrophy.

  2025cites this paper
• Sex-specific adipose-muscle patterns from CT reveal metabolic syndrome risk in the elderly with machine learning.

  2025cites this paper
• Antisense-mediated exon skipping therapy improves neuromuscular junction deficits in a Duchenne muscular dystrophy mouse model.

  2025cites this paper
• CRISPR-Cas technologies: Emerging tools from research to clinical application.

  2025cites this paper
• The Impact of Aquaporin‐4 Deletion on K+‐Induced Astrocytic Swelling Depends on K+ Concentration

  2025cites this paper
• Exploring new therapeutics for Duchenne muscular dystrophy and related cardiomyopathy

  2025cites this paper
• The Promise and Pitfalls of AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy

  2025cites this paper
• AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects

  2025cites this paper
• Obligatory and accessory respiratory muscle structure, function and control in early and advanced disease in the mdx mouse model of Duchenne muscular dystrophy

  2025cites this paper
• Copy number variants (CNV) interfere with human Accelerated Regions (HARs) to cause neurodevelopmental disorders: a large-scale cohort study

  2025cites this paper
• L-Arginine Activates the Neuregulin-1/ErbB Receptor Signaling Pathway and Increases Utrophin mRNA Levels in C2C12 Cells

  2025cites this paper
• Multiparametric Analysis of Nasal Inspiratory Pressure (SNIP) in Duchenne Muscular Dystrophy: A Case‐Control Study With Healthy Subjects

  2025cites this paper
• Diagnóstico y manejo de las complicaciones cardiacas en el paciente con distrofia muscular de Duchenne

  2025cites this paper
• The experience of treating patients with Duchenne myodystrophy caused by nonsense mutation

  2025cites this paper
• Periostin Exon 17 Skipping Enhances the Efficacy of Local Adeno-Associated Viral-Microdystrophin Administration in a Fibrotic Model of Duchenne Muscular Dystrophy

  2025cites this paper
• Central Neurophysiological Alterations in Dystrophic mdx Mice Correlate With Reduced Hippocampal Levels of the Endogenous NMDA Receptor Ligand D‐Aspartate

  2025cites this paper
• Identification of dystrophin Dp71dΔ71-associated proteins in PC12 cells by quantitative proteomics.

  2024cites this paper
• Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy

  2024cites this paper
• Molecular Study of the Fukutin-Related Protein (FKRP) Gene in Patients from Southern Italy with Duchenne/Becker-like Phenotype

  2024cites this paper
• Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–Phosphorodiamidate Morpholino Oligomer Conjugates for Drug Development

  2024cites this paper
• Perfil de pacientes com doenças neuromusculares em um hospital universitário da região norte do Brasil

  2024cites this paper
• Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model

  2024cites this paper
• Design of a Telerehabilitation System Including Electromyography Driven Dynamic Arm Support for Duchenne Muscular Dystrophy Patients

  2024cites this paper
• Exome sequencing revealed variants in SGCA and SIL1 genes underlying limb girdle muscular dystrophy and Marinesco–Sjögren syndrome patients

  2024cites this paper
• Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models

  2024cites this paper
• Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice

  2024cites this paper
• Neurexin facilitates glycosylation of Dystroglycan to sustain muscle architecture and function in Drosophila

  2024cites this paper
• Essential components of an effective transition from paediatric to adult neurologist care for adolescents with Duchenne muscular dystrophy; a consensus derived using the Delphi methodology in Eastern Europe, Greece and Israel

  2024cites this paper
• Advanced Heart Failure Therapies in Neuromuscular Diseases

  2024cites this paper
• Pathophysiological role of connexin and pannexin hemichannels in neuromuscular disorders

  2024cites this paper
• Does Motor Function Differ According to the Site of Mutation in Duchenne Muscular Dystrophy?

  2024cites this paper
• Long-term clinical follow-up of a family with Becker muscular dystrophy associated with a large deletion in the DMD gene.

  2024influential citation
• Motor dysfunction of the gut in Duchenne muscular dystrophy: A review

  2024cites this paper
• The unconditioned fear response in vertebrates deficient in dystrophin.

  2024cites this paper
• Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part I: the period before etiotropic approaches introduction

  2024cites this paper
• Identification of pivotal genes and pathways in Chorea-acanthocytosis using comprehensive bioinformatic analysis

  2024cites this paper
• Non-viral delivery of nucleic acid for treatment of rare diseases of the muscle

  2024cites this paper
• Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse

  2024cites this paper
• Endomysium determines active and passive force production in muscle fibers.

  2024cites this paper
• Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case

  2024cites this paper
• A Comprehensive Review of Muscle–Tendon Junction: Structure, Function, Injury and Repair

  2024cites this paper
• Distribution and appearance of myosin, dystrophin, and collagen IV in strabismus-affected extraocular muscle tissue compared with control tissue

  2024cites this paper
• Duchenne and Becker muscular dystrophy: Cellular mechanisms, image analysis, and computational models: A review

  2024cites this paper
• CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments

  2024cites this paper
• The role of ataluren in the treatment of ambulatory and non-ambulatory children with nonsense mutation duchenne muscular dystrophy - a consensus derived using a modified Delphi methodology in Eastern Europe, Greece, Israel and Sweden

  2024cites this paper
• Cross-species modeling of muscular dystrophy in Caenorhabditis elegans using patient-derived extracellular vesicles

  2024cites this paper
• Biophysical characterization of the dystrophin C-terminal domain: Dystrophin interacts differentially with dystrobrevin isoforms

  2024cites this paper
• Research hotspots and trends for Duchenne muscular dystrophy: a machine learning bibliometric analysis from 2004 to 2023

  2024cites this paper
• Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part II: etiotropic approaches

  2024cites this paper
• Unveiling the potential of antisense oligonucleotides: Mechanisms, therapies, and safety insights

  2024cites this paper
• BREATHE DMD: boosting respiratory efficacy after therapeutic hypoxic episodes in Duchenne muscular dystrophy

  2024cites this paper
• Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy

  2023cites this paper
• Assessment of Extracellular Volume Fraction in Becker Muscular Dystrophy by Using MR Fingerprinting.

  2023cites this paper
• New advancements in CRISPR based gene therapy of Duchenne Muscular dystrophy.

  2023cites this paper
• Modeling Reduced Contractility and Stiffness Using iPSC-Derived Cardiomyocytes Generated From Female Becker Muscular Dystrophy Carrier

  2023cites this paper
• Insights into Cell-Specific Functions of Microtubules in Skeletal Muscle Development and Homeostasis

  2023cites this paper
• The vitamin B3 analogue nicotinamide riboside has only very minor effects on reducing muscle damage in mdx mice

  2023cites this paper
• Trichinella spiralis (Owen, 1835) Induces Increased Dystrophin Expression in Invaded Cross-striated Muscle

  2023influential citation
• Is the fundamental pathology in Duchenne's muscular dystrophy caused by a failure of glycogenolysis–glycolysis in costameres?

  2023cites this paper
• Spectrum of Genetic Variants in the Dystrophin Gene: A Single Centre Retrospective Analysis of 750 Duchenne and Becker Patients from Southern Italy

  2023cites this paper
• Ion Channels of the Sarcolemma and Intracellular Organelles in Duchenne Muscular Dystrophy: A Role in the Dysregulation of Ion Homeostasis and a Possible Target for Therapy

  2023cites this paper
• Change in the spectrum of detected mutations in the DMD gene depending on the methodological capabilities of the laboratory

  2023cites this paper
• Neuroprotective Effects of Sertoli Cells in Movement Disorders

  2023cites this paper
• Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review

  2023cites this paper
• Identification of Genetic Variants Associated with Severe Myocardial Bridging through Whole-Exome Sequencing

  2023cites this paper
• Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy

  2023cites this paper
• Duchenne Muscular Dystrophy: Modern Approaches in Patient Management

  2023cites this paper
• Risk of Obstructive Sleep Apnea in Saudi Male Boys with Duchenne Muscular Dystrophy (DMD)

  2023cites this paper
• The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

  2023influential citation
• Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec

  2023cites this paper
• Comparative Analysis of Muscle Atrophy During Spaceflight, Nutritional Deficiency and Disuse in the Nematode Caenorhabditis elegans

  2023cites this paper
• Role of CRISPR/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies.

  2023cites this paper
• Consensus concept of modern effective therapy for Duchenne muscular dystrophy

  2023cites this paper
• Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors

  2023cites this paper
• CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy

  2023cites this paper
• Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model

  2023cites this paper
• Microdystrophin Gene Addition Significantly Improves Muscle Functionality and Diaphragm Muscle Histopathology in a Fibrotic Mouse Model of Duchenne Muscular Dystrophy

  2023cites this paper
• Behavioral / Systems / Cognitive Abnormal Dysbindin Expression in Cerebellar Mossy Fiber Synapses in the mdx Mouse Model of Duchenne Muscular Dystrophy

  2023cites this paper